Advances in Multiple Sclerosis and Experimental Demyelinating Diseases by

Advances in Multiple Sclerosis and Experimental Demyelinating Diseases

Current Topics in Microbiology and Immmunology

362 pages missing pub info (editions)

nonfiction health
Powered by AI (Beta)
Loading...

Description

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural his...

Read more

Community Reviews

Loading...

Content Warnings

Loading...